We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abbott Labs to Acquire Vysis

By HospiMedica staff writers
Posted on 01 Nov 2001
In a move to expand its offerings in molecular diagnostics, Abbott Laboratories (Abbott Park, IL, USA) has agreed to acquire Vysis, Inc. More...
(Downers Grove, IL, USA), a leading developer of innovative molecular diagnostic products. The transaction is valued at around US$355 million. As part of the transaction, Abbott has entered into an agreement with Amoco Technology Company for its holdings of around 65% of outstanding Vysis shares.

Vysis has developed tests for breast cancer (PathVysion HER-2 DNA Probe Kit) and bladder cancer recurrence (UroVysion), based on the company's proprietary fluorescence in situ hybridization (FISH) DNA probe technology that can detect changes in genes or chromosomes. Other Vysis products include tests for prenatal abnormalities, chronic myelogenous leukemia, and chronic lymphocytic leukemia.

"This acquisition further strengthens our position in molecular diagnostics, with a portfolio of innovative tests for the detection of chromosomal and gene abnormalities,” said Thomas D. Brown, senior vice president, diagnostic operations, Abbott Laboratories.




Related Links:
Abbott Labs
Vysis

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Blood Gas Analyzer
i-Check200
New
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Even though the team’s new bioelectronic is only about the size of a fingertip, it could offer an effective and biocompatible approach to addressing high blood pressure (photo courtesy of Tao Zhou/Penn State)

Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study

Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.